Want to see TSE:GLOW full AI Analyst Report?
GLOW Stock Chart & Stats
C$0.04
C$0.00(0.00%)
At close: 4:00 PM EDT
C$0.04
C$0.00(0.00%)
Day’s Range― - ―
52-Week RangeC$0.04 - C$0.08
Previous CloseN/A
Volume19.80K
Average Volume (3M)266.05K
Market Cap
C$8.66M
Enterprise ValueC$8.51
Total Cash (Recent Filing)C$1.59M
Total Debt (Recent Filing)C$45.48K
Price to Earnings (P/E)―
Beta0.20
Next Earnings
Sep 01, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding192,435,550
10 Day Avg. Volume165,602
30 Day Avg. Volume266,047
Financial Highlights & Ratios
PEG Ratio0.19
Price to Book (P/B)3.82
Price to Sales (P/S)5.04
P/FCF Ratio-87.53
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strong Revenue Growth And Narrowing LossesSustained high revenue growth (TTM revenue up materially) combined with narrower losses shows improving product-market fit and operating leverage potential. Over 2-6 months this trend supports a pathway to break-even as scale reduces per-unit costs and funds R&D.
Low Leverage Provides Financial FlexibilityLow debt reduces interest burden and preserves borrowing capacity, allowing the company to fund clinical and growth programs without immediate refinancing pressure. This structural balance-sheet strength supports strategic options during a multi-quarter development cycle.
Material Improvement In Free Cash Flow RecentlyA notable improvement in free cash flow indicates operating improvements and better capital allocation. If sustained, this reduces reliance on external financing, lengthens runway, and supports incremental investment in commercialization or R&D over the medium term.
Bears Say
Negative Operating Cash Flow And Ongoing Cash BurnPersistent negative operating cash flow means the core business is not yet self-funding and will need external capital to sustain operations. Over months this elevates dilution and execution risk, constraining long-term investment and strategic flexibility if cash burn persists.
Persistent Negative Operating Profit And Negative EBITDANegative operating profit and EBITDA reflect that core operations do not generate sustainable earnings. Without a clear margin-improvement roadmap, the company faces ongoing losses that impair return metrics and make achieving investor-aligned profitability more challenging.
History Of Balance-sheet Volatility And Prior Negative EquityA prior episode of negative equity signals past solvency stress and susceptibility to capital shocks. Recurrence would force dilutive financing or asset sales; this structural volatility increases long-term financing and counterparty risks for partnerships and suppliers.
Glow LifeTech News
GLOW FAQ
What was Glow LifeTech’s price range in the past 12 months?
Glow LifeTech lowest stock price was C$0.04 and its highest was C$0.07 in the past 12 months.
What is Glow LifeTech’s market cap?
Glow LifeTech’s market cap is C$8.66M.
When is Glow LifeTech’s upcoming earnings report date?
Glow LifeTech’s upcoming earnings report date is Sep 01, 2026 which is in 34 days.
How were Glow LifeTech’s earnings last quarter?
Currently, no data Available
Is Glow LifeTech overvalued?
According to Wall Street analysts Glow LifeTech’s price is currently Overvalued.
Does Glow LifeTech pay dividends?
Glow LifeTech does not currently pay dividends.
What is Glow LifeTech’s EPS estimate?
Glow LifeTech’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Glow LifeTech have?
Glow LifeTech has 192,435,550 shares outstanding.
What happened to Glow LifeTech’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Glow LifeTech?
Currently, no hedge funds are holding shares in TSE:GLOW
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Glow LifeTech
Glow Lifetech Corp. is a biotechnology enterprise based in North America, dedicated to the development and marketing of nutraceutical and cannabinoid-derived products. The company is actively commercializing two core technologies: MyCell Enhanced technology, which facilitates the optimal delivery of nutrients for both nutraceuticals and cannabis, and a Cannabis Smart Consumption System, designed to help users and patients store, track, manage, and consume cannabis products effectively. Glow Lifetech possesses exclusive rights throughout North America for the production, sale, and distribution of a specific micellization technology, applicable to cannabis and hemp-derived ingredients, curcumin, Vitamin K, and iron. A key aspect of their operations involves the advanced processing of ingredients, converting certain vitamins, nutraceuticals, and cannabis extracts into micellized forms. This process significantly boosts the bioavailability of fat-soluble compounds, ensuring near 100% absorption into the body and enhancing their compatibility with water. The company, founded in 2018, is headquartered in Toronto, Canada.
Technical Analysis
COSCIENS Biopharma
―
Kane Biotech
―
Quest Pharmatech
―
PreveCeutical Medical
―
PharmAla Biotech Holdings, Inc.
―